Abstract P3-14-04: Tailored duration of adjuvant trastuzumab for early human epidermal growth factor receptor 2-positive breast cancer

Authors: Ke-Da Yu, Zhi-Rui Zhou, Zhi-Ming Shao

Published: 2020-03-26

DOI: 10.1158/1538-7445.sabcs19-p3-14-04

Source: Full article

---

Abstract

Abstract